iMeta | Cardiovascular disease therapeutics via engineered oral microbiota

Описание к видео iMeta | Cardiovascular disease therapeutics via engineered oral microbiota

https://doi.org/10.1002/imt2.197

Graphical Abstract
Engineering bacteria are considered as a potential treatment for cardiovascular diseases and related risk factors. Oral bacteria are closely related to the occurrence and development of cardiovascular diseases, and their engineering has broad prospects and potential in the treatment of cardiovascular diseases. Oral pathogenic bacteria undergo protein and genetic engineering, including the incorporation of exogenous plasmids to yield therapeutic effects; genetically engineered oral probiotics can be harnessed to secrete cytokines and reactive oxygen species, offering novel therapeutic avenues for cardiovascular diseases.

Комментарии

Информация по комментариям в разработке

Похожие видео